About Veterinary Medicine
Veterinary medicine in treating as any drug used to treat a wide range of medical diseases in domestic animals. Veterinary medicine, for example, includes medications such as anti-infective treatments and parasiticides that are administered orally to animals to treat a variety of ailments. Vaccines are also used in veterinary medicine to immunise animals against a variety of viral diseases. They also include medicated feed additives, which are mixed with animal feed to provide medicinal effects to the animals receiving the feed.
|Unit||Value (USD Million)|
The market for Veterinary medicine is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Veterinary Medicine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Zoetis, Inc. (United States), Mindray Medical International Limited (China), Smiths Group plc (United Kingdom), Nonin Medical (United States), Digicare Biomedical (United States), DRE Veterinary (United States), Midmark Corporation (United States), Jorgensen Laboratories (United States), Grady Medical Systems (United States), MILA International (United States), Burtons Medical (United Kingdom), Merck & Co., Inc. (United States), Eli Lilly and Company (United States), Bayer Healthcare AG (Germany) and Ceva Santé Animale (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Virbac S.A (France), Vetoquinol SA (France), Boehringer Ingelheim GmbH (Germany), Nutreco N.V.(Netherlands) and Sanofi S.A. (France).
AMA Research has segmented the market of Global Veterinary Medicine market by Type (Pharmaceuticals, Vaccines and Others), Application (Companion Animals and Farm Animals) and Region.
On the basis of geography, the market of Veterinary Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Veterinary Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Veterinary Clinics will boost the Veterinary Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Veterinary Medicine Market Dynamics:
- Growing Number Of Vets In Developing Countries
- Growing Demand For Animal Welfare
- Advancement In Medical Technology And Increasing Research And Development Activities
- Lack Of Skilled Veterinarians
|Road Blocks / Challenges|
- Lack Of Infrastructure And Funding And Use Of Counterfeit Medicines
|Gaps & Opportunities|
- Increasing Investment For Healthcare Infrastructure
- Rising Awareness Towards Animal Health
On 24 April 2021 Hester Biosciences announced that on the occasion of World Veterinary Day, the company has launched a new range of Herbal Products for livestock and poultry in its existing range of products to support the overall wellbeing of animals, and to supplement our existing product range
On 28 January 2022, the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) becomes applicable. It contains new measures for stimulating innovation and increasing the availability and access to safe and high-quality veterinary medicines for veterinarians, farmers and pet owners to treat and prevent animal diseases and also supports the European Union (EU) action against antimicrobial resistance (AMR).
Key Target Audience
New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.